BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21553300)

  • 1. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
    Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
    Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys.
    Mundiñano IC; Hernandez M; Dicaudo C; Ordoñez C; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2013 Sep; 126(3):411-25. PubMed ID: 23784261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.
    Doorn KJ; Goudriaan A; Blits-Huizinga C; Bol JG; Rozemuller AJ; Hoogland PV; Lucassen PJ; Drukarch B; van de Berg WD; van Dam AM
    Brain Pathol; 2014 Mar; 24(2):152-65. PubMed ID: 24033473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb.
    Sengoku R; Saito Y; Ikemura M; Hatsuta H; Sakiyama Y; Kanemaru K; Arai T; Sawabe M; Tanaka N; Mochizuki H; Inoue K; Murayama S
    J Neuropathol Exp Neurol; 2008 Nov; 67(11):1072-83. PubMed ID: 18957894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
    Nuber S; Petrasch-Parwez E; Arias-Carrión O; Koch L; Kohl Z; Schneider J; Calaminus C; Dermietzel R; Samarina A; Boy J; Nguyen HP; Teismann P; Velavan TP; Kahle PJ; von Hörsten S; Fendt M; Krüger R; Riess O
    Neurobiol Dis; 2011 Nov; 44(2):192-204. PubMed ID: 21767644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
    Huisman E; Uylings HB; Hoogland PV
    Mov Disord; 2004 Jun; 19(6):687-92. PubMed ID: 15197709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
    Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
    Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.
    Ho CY; Troncoso JC; Knox D; Stark W; Eberhart CG
    Brain Pathol; 2014 Jan; 24(1):25-32. PubMed ID: 23714377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia.
    Jellinger KA
    Neurodegener Dis; 2008; 5(3-4):118-21. PubMed ID: 18322367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
    Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
    Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease.
    Saiz-Sanchez D; Ubeda-Bañon I; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Insausti R; Martinez-Marcos A
    Exp Neurol; 2010 Jun; 223(2):347-50. PubMed ID: 19559700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
    Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.
    Huisman E; Uylings HB; Hoogland PV
    Mov Disord; 2008 Jul; 23(10):1407-13. PubMed ID: 18581481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.
    Kohl Z; Schlachetzki JC; Feldewerth J; Hornauer P; Münch M; Adame A; Riemenschneider MJ; Winkler J; Masliah E
    Neural Plast; 2017; 2017():3851262. PubMed ID: 28409032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.
    Carmona-Abellan M; Martinez-Valbuena I; Marcilla I; DiCaudo C; Gil I; Nuñez J; Luquin MR
    Neurol Sci; 2021 Apr; 42(4):1473-1482. PubMed ID: 32816165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
    Jellinger KA
    Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.